Morphological and molecular profiles and pathways in bladder neoplasms.

Area of Science:

• Urogenital Pathology
• Molecular Oncology
• Cancer Genomics

Background:

• The World Health Organization (WHO) grading system for bladder neoplasms has evolved, with the 2004 WHO system replacing the 1973 WHO system.
• Concerns exist among experts regarding the nomenclature and grading categories of the 2004 WHO system for bladder neoplasms.

Purpose of the Study:

• To evaluate the impact of molecular and genetic findings on the classification and prognosis of urothelial neoplasms.
• To explore the correlation between molecular alterations and the 2004 WHO classification of bladder cancer.

Main Methods:

• Analysis of molecular and genetic studies, including gene mutation identification (e.g., fibroblast growth factor receptor 3) and cDNA profiling.
• Correlation of molecular findings with the established 2004 WHO bladder cancer classification system.

Main Results:

• Identification of fibroblast growth factor receptor 3 gene mutations in over 50% of urothelial carcinomas.
• Discovery of distinct cDNA profiles characterizing different subsets of bladder cancer.
• Demonstration of a strong correlation between molecular findings and the 2004 WHO classification, as well as patient prognosis.

Conclusions:

• Molecular and genetic insights offer a new perspective on urothelial neoplasm classification.
• The 2004 WHO classification aligns with key molecular findings, supporting its utility in predicting bladder cancer prognosis.